GEMCITABINE AND CARBOPLATIN IN TREATING PATIENTS WITH PERSISTENT OR RECURRENT OVARIAN EPITHELIAL CANCER, PRIMARY PERITONEAL CANCER, OR FALLOPIAN TUBE CANCER THAT RESPONDED TO PREVIOUS CISPLATIN OR CARBOPLATIN: